FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $766,391 | +48375.1% | 86,794 | -54.3% | 0.00% | -100.0% |
| Q1 2023 | $1,581 | +29.4% | 189,998 | +49.3% | 0.00% | 0.0% |
| Q4 2022 | $1,222 | -99.9% | 127,289 | -48.9% | 0.00% | 0.0% |
| Q3 2022 | $2,020,000 | +50.6% | 249,337 | +5.0% | 0.00% | 0.0% |
| Q2 2022 | $1,341,000 | -5.2% | 237,392 | -6.0% | 0.00% | 0.0% |
| Q1 2022 | $1,415,000 | +24.8% | 252,679 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $1,134,000 | -53.3% | 257,617 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,427,000 | -17.8% | 257,621 | -36.4% | 0.00% | -50.0% |
| Q2 2021 | $2,951,000 | +2488.6% | 404,772 | +2010.4% | 0.00% | – |
| Q1 2020 | $114,000 | -40.3% | 19,180 | -59.7% | 0.00% | – |
| Q2 2019 | $191,000 | -82.9% | 47,634 | -48.6% | 0.00% | -100.0% |
| Q1 2018 | $1,120,000 | – | 92,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |